Source:  NC BIOTECH, 8/19/22

GreenLight Biosciences has gotten the green light for $109 million in additional funding to help finance the development of its ribonucleic acid (RNA)-based technology for agricultural and human applications. GreenLight uses its patented cell-free RNA manufacturing platform for a variety of crop protection and human health purposes. The technology can build RNA strands that precisely target specific genes in plants, animals, or fungi, beneficially suppressing the activity of those genes.

For more of this story, click here.